NCT05637567View on ClinicalTrials.gov

Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

170

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

September 30, 2028

Study Completion Date

March 31, 2029

Conditions

Pancreatic Cancer Resectable

Interventions

DRUG

Acetylsalicylic acid

100 mg per os once daily

DRUG

Placebo

Placebo pill per os once daily

All Listed Sponsors

lead

German Cancer Research Center

OTHER